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Summary
Understanding, treating, and preventing diseases
caused by immunosuppression and/or persistent in-
fections remain both a major challenge in biomedical
research and an important health goal. For a virus or
any infectious agent to persist, it must utilize strate-
gies to suppress or evade the host’s immune re-
sponse. Here, we report that two dissimilar viruses
employ a common maneuver to cause a profound im-
munosuppression. Measles virus (MV) and lympho-
cytic choriomeningitis virus (LCMV) interfere with
dendritic cell (DC) development and expansion in vivo
and in vitro. The underlying mechanism for this is
through the generation of type I interferon (IFN) that
acts via a signal transducer and activator of a tran-
scription (STAT)2-dependent, but STAT1-independent,
pathway. Thus, viruses subvert the known antiviral ef-
fect of type I IFN through STAT2-specific signaling to
benefit their survival. These observations have impli-
cations for understanding and developing therapies
to treat diseases caused by immunosuppression and/
or persistent infections.
Introduction
From the time Isaacs and Lindenmann (1957) discov-
ered IFN up to the present (Biron and Sen, 2001; Darnell
et al., 1994; Grandvaux et al., 2002), the ability of IFNs
to protect against viral infections has been continu-
ously reaffirmed. Different from type II IFN (IFN-ϒ),
which is made primarily by T cells after induction of the
adaptive immune responses, type I IFN, a major com-
ponent of the innate immune system, comprises of a
family of closely related proteins (IFN-α) and a single
gene product (IFN-β) induced early during infection that
inhibit virus replication after binding to a common re-
ceptor (receptor for IFN-α and IFN-β, IFNAR) (Muller et
al., 1994) coupled to a Janus kinase (JAK). The resulting
events are activation of STAT1 and STAT2 followed by
the formation of interferon-stimulated gene factor 3
(ISGF3) complex composed of STAT1, STAT2, and IFN
regulatory factor 9, which promotes serial synthesis of
selected proteins that inhibit viral replication (Aaronson
and Horvath, 2002; Darnell et al., 1994).
As an immunological modulator, type I IFNs selec-
tively enhance clonal expansion and survival of CD8+ T
cells (Tough et al., 1996), skew the immune response to*Correspondence: mbaobo@scripps.eduTh1-like phenotype (Brinkmann et al., 1993), and acti-
vate natural killer (NK) cells (Biron, 2001). It has been
also proposed that type I IFNs regulate differentiation
and maturation of the professional antigen-presenting
DCs (Dauer et al., 2003; Honda et al., 2003, 2004;
Hoebe et al., 2003; Ito et al., 2001; Luft et al., 1998;
McRae et al., 2000 Mohty et al., 2003; Paquette et al.,
1998; Santodonato et al., 2003). However, the reports
on the biological significance and underlying molecular
mechanisms of virus-induced type I IFN’s role in DC
development are often conflicting and thus unclear.
DCs stimulate naive T cells potently to induce adap-
tive immune responses (Banchereau and Steinman,
1998). Owing to DC’s seminal role controlling host im-
mune responses, they are ideally targeted by multiple
viruses. For example, HIV can utilize DC to transfer in-
fection to T cells in lymphoid organs (Geijtenbeek et al.,
2000; Kwon et al., 2002; Steinman et al., 2003). Viral
infection can also have a dramatic impact on DC and
can result in inhibition of signaling pathways involved
in DC maturation as observed in herpes simplex virus
infection (Salio et al., 1999), functional impairment of
DC via murine cytomegalovirus (andrews et al., 2001),
as well as induction of apoptosis in monocyte precur-
sors by contact with Epstein-Barr virus (Li et al., 2002).
Recently, we demonstrated that an immunosuppressive
strain of LCMV Clone 13 (Cl 13) aborted the function of
DCs by inducing downregulation of costimulatory
molecules and inhibiting DC expansion (Sevilla et al.,
2004).
To further examine the interaction of virus with DC
network, we studied infections with MV as well as
LCMV. MV routinely causes profound immunosuppres-
sion in humans that is responsible for most measles-
related fatalities (Griffin, 2001; McChesney and Oldstone,
1989). Explanations for how MV induces suppression of
the immune system include suppression of T and B cell
proliferation by cell cycle block or through MV infection
of DCs, apoptosis of T lymphocytes, Fas-mediated
apoptosis of DCs, inhibition of CD40 ligand-dependent
terminal differentiation of DCs, deregulation of cytokine
production, and disruption of hematopoiesis (Fugier-
Vivier et al., 1997; Grosjean et al., 1997; Hahm et al.,
2003, 2004; Joseph et al., 1975; Karp et al., 1996;
Klagge et al., 2000; Manchester et al., 2002; McChes-
ney et al., 1987, 1988; Naniche et al., 1999; Schneider-
Schaulies et al., 2003; Servet-Delprat et al., 2000, 2003;
Slifka et al., 2003; Sun et al., 1998). However, exact mo-
lecular mechanisms of occurrence and maintenance of
MV-caused immunosuppression rendering infected in-
dividuals vulnerable to secondary microbial infections
are still not clearly understood.
In this report, we utilized mouse genetics of both
transgenic (Tg) mice expressing MV receptor human (h)
SLAM (Tatsuo et al., 2000) on DCs (Hahm et al., 2004)
and knockout mice lacking specific genes to immuno-
regulatory pathways to clearly demonstrate that MV in-
hibits DC development through type I IFNs. Underlying
molecular mechanism is done through type I IFN-medi-
ated STAT2 activation, which is STAT1 independent, re-
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pLCMV Cl 13 utilizes the same signaling pathway to sup-
press DC expansion in vivo. Overall, these findings sug- d
1gest a common mechanism by which viruses that in-





mMV Inhibits Development of DCs from Hematopoietic
iBone Marrow Cells
tIn order to analyze and manipulate MV-DC interactions,
Fwe created Tg mice expressing the MV receptor hSLAM
ion DCs (see Figure S1 available online with this article)
dunder control of CD11c promoter (Hahm et al., 2004).
tTo investigate whether MV infection affects the devel-
iopment of CD11c+ DCs, pluripotent hematopoietic
ebone marrow (BM) cells were cultured for 3 days in the
cpresence of GM-CSF, infected with MV, recultured in
GM-CSF-containing media, and monitored for the gen-
eration of CD11c+ cells at 3 and 6 days postinfection T
I(dpi). Mock-infected BM cells from Tg mice generated
CD11c+ cells (0 dpi, 24%; 3 dpi, 59%; and 6 dpi, 77%; W
DFigure 1A) similar to mock-infected or MV-infected non-
Tg BM cells (data not shown). By contrast, MV infected C
gCD11c+ cells expressing hSLAM receptor and signifi-Figure 1. Inhibition of DC Development by
MV Infection
(A) BM cells from Tg mice were cultured with
GM-CSF for 3 days and then mock infected
or infected with MV. At days 0 (open box), 3
(shaded box), and 6 (black box) postinfec-
tion (dpi), the percentage of CD11c+ cells
was analyzed. Data represent mean ± SD
from three independent experiments.
(B) BM cells from Tg mice were cultured with
Flt3-L for 2 days and then mock infected or
infected with MV. At 5 dpi, the percentage of
CD11c+ cells was analyzed as in (A).
(C) BM cells from Tg mice were cultured for
2 days and then mock infected or infected
with MV. Cells were cultured in GM-CSF-
supplemented media for 4 days and then
treated with LPS for 1 day. The expression
of CD11c, MHC-II, B7-1, B7-2, and CD40
molecules was assessed by FACS.
(D) After mock or MV infection, cells were
cultured for 5 days and then treated with
LPS for 6 hr. The intracellular production of
IL-12 over the last 5 hr was assessed by
FACS.antly inhibited the development of CD11c+ DCs in the
resence of GM-CSF (0 dpi, 24%; 3 dpi, 23%; and 6
pi, 26%) (Figure 1A) or Flt3-L (mock, 63% and MV,
9%) (Figure 1B). Further, MV significantly aborted the
xpression of the major histocompatibility complex
MHC) class II and costimulatory molecules CD40,
7-1, and B7-2, which are required for efficient antigen
resentation of DCs to stimulate naive T cells, even af-
er lipopolysaccharide (LPS) was added to enhance ter-
inal maturation of DCs (Figure 1C). MV infection also
nhibited the production of the immunoregulatory cy-
okine IL-12 in the presence of GM-CSF (Figure 1D) or
lt3-L (data not shown). MV replication was required for
nhibition of DC generation, as inactivated MV failed to
ownregulate these molecules (Figure S2A). MV V pro-
ein has been suggested to play a role in MV-induced
mmunosuppression (Palosaari et al., 2003; Patterson
t al., 2000; Takeuchi et al., 2003), but it was not the
ause in our studies (Figure S2B).
he Inhibition of DC Differentiation by MV Infection
s Mediated by Type I IFNs
e found that type I IFNs were involved in inhibition of
C expansion by MV. For these experiments, we bred
D11c-hSLAM Tg mice with IFNAR−/− mice, thereby
enerating mice that expressed hSLAM on DCs but
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249were deficient in a type I IFN receptor. Then BM cells,
which lacked type I IFN signaling capacity, were in-
fected with MV and tested for the ability to generate
DCs. As shown in Figure 2A, MV infection of Tg BM
cells bearing IFNAR inhibited the development of MHC-
II+CD11c+ cells from precursor BM cells when com-
pared to uninfected cells (Figure 2A, 76% to 14%). In
contrast, the inhibition of CD11c+ DC generation caused
by MV infection was not observed when type I IFN sig-
naling was absent. Similar levels of MHC-II+CD11c+
cells were obtained after mock infection or MV infection
of BM cells from hSLAM Tg × IFNAR−/− mice (Figure 2A,
63% to 58%). These results indicated that MV-induced
type I IFNs suppressed DC differentiation. As expected,
MV induced RNA expression of type I IFNs, IFN-β and
IFN-α (IFN-α4, 66%; other various IFN-α, 33% by IFN-α
subtyping), at 20 hr postinfection (hpi) (Figure 2B). Add-
ing recombinant (r) IFN-β (1000 U/ml), in the absence of
MV infection, onto the uninfected culture mimicked the
effect of virus infection and prevented DC precursor
cells from differentiating into CD11c+ DCs in the pres-
ence of Flt3-L (Figure 2C, 67% to 11%) or GM-CSF (Fig-
ure 2D). Inhibition of DC differentiation by rIFN-β was
dose responsive (Figure 2D), requiring approximately
2000 U/ml for complete inhibition (50% inhibitory con-
centration, IC50 z 200 U/ml).
Proliferation of Tg BM cells in GM-CSF-supple-
mented media as judged by the decrease of CFSE fluo-
rescence was inhibited by MV treatment resulting in
loss of DC-specific large colonies (Figure 2E). However,Figure 2. Inhibition of DC Expansion Is
Caused by MV-Induced Type I IFNs
(A) BM cells were harvested from hSLAM Tg
(Tg) or hSLAM Tg crossed with type I IFN
receptor knock out mice (Tg × IFNAR−/−). 5
dpi with MV, generation of CD11c+MHC
class II+ DCs was assessed by FACS.
(B) RNAs were isolated from either mock-
infected or MV-treated cells from Tg mice at
20 hpi. RT-PCR analysis was performed to
detect RNA transcripts of IFN-α and IFN-β.
(C) BM cells from wt mice were cultured with
or without rIFN-β (1000 U/ml) in Flt3-L-sup-
plemented cultures. After 5 days, differentia-
tion of BM cells into CD11c+ DCs was ana-
lyzed.
(D) BM cells from wt mice were cultured with
increasing doses of rIFN-β (from 0 U/ml to
2500 U/ml) for 5 days in the presence of GM-
CSF, and generation of CD11c+MHC class II+
DCs was analyzed.
(E) BM cells from Tg or Tg × IFNAR−/− were
stained with CFSE and inoculated with con-
trol cell supernatant (mock infection, solid
line) or MV (filled histogram). The decrease
of CFSE fluorescence was monitored at day
0 (dotted line, d0) and day 5 (d5). DC-specific
large colonies generated from loosely adher-
ent cells are shown on the right.
(F) Cell viability at 5 dpi was analyzed by
staining cells with Annexin V, a marker pro-
tein for early apoptotic cells, and 7-AAD to
exclude dead cells.the impairment of cell division was not observed in the
culture of BM cells deficient in IFNAR, indicating virus-
induced type I IFNs exhibited antiproliferative activity
to limit DC expansion. Importantly, the suppression of
DC expansion was not due to MV-induced apoptosis,
as total cell viability (viable cells: annexin V[−] and
7-AAD[−] cells) detected at 2, 3, 4 (data not shown), or
5 dpi (Figure 2F) was not significantly altered by MV
treatment of cells.
In contrast to our results showing that type I IFNs
aborted DC differentiation, other investigators reported
that type I IFNs enhance DC differentiation and matura-
tion (Honda et al., 2003, 2004; Hoebe et al., 2003; Ito et
al., 2001; Luft et al., 1998; Mohty et al., 2003; Paquette
et al., 1998; Santodonato et al., 2003). To clarify and
separate the effect of type I IFNs on DC development
and DC terminal maturation, wild-type (wt) BM cells as
DC precursors (Figure 3A) and DCs generated in the
GM-CSF-supplemented culture for 10 days as a source
of committed DCs (Figure 3B) were treated with rIFN-β.
As noted in Figures 2C and 2D, rIFN-β treatment
aborted the production of DCs represented as MHC-
II+CD11c+ cells and B7-2+(high and medium) CD11c+ cells
(Figure 3A). In contrast, rIFN-β exhibited stimulatory ac-
tivity on committed DCs by increasing the level of co-
stimulatory molecules such as B7-2 (2.7-fold increase
of mean fluorescence intensity [MFI]) and CD40 (2.5-
fold increase), and MHC-I (2.2-fold increase) and MHC-
II (1.5 fold increase) on DCs (Figure 3B, data not shown
for CD40 and MHC-I). These results indicate that type I
Immunity
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velopment and Terminal Maturation of DCs
(A) BM cells from wt mice were cultured with
or without rIFN-β (1000 U/ml) for 5 days in
the presence of GM-CSF and generation of
CD11c+MHC class II+ DCs and CD11c+B7-
2+(high and medium) DCs was analyzed.
(B) DCs were generated from BM cells har-
vested from wt mice through the GM-CSF-
supplemented culture system for 10 days.
They were treated with or without rIFN-β
(2000 U/ml) for 3 days and analyzed as in (A).IFNs can both positively and negatively alter DCs de- p
fpending upon the differentiation state of the DC pop-
ulation. Our results thus extend and clarify the opposite o
prole of type I IFNs on DC development versus DC ter-
minal maturation. S
p
wMV-Induced Suppression of DC Development
Is Dependent on STAT2 Signaling f
cbut Independent of the STAT1 Signaling Pathway
To further define the molecular mechanism of IFN- d
smediated inhibition of DC development, a transwell ex-
periment was employed that permitted usage of cells i
afrom selected knockout mice lacking MV receptors. The
chamber containing membrane separates and prevents d
dthe migration of cells in the upper well from cells in the
bottom well and vice versa but allows diffusion of small n
molecules produced from the cells. As expected, MV-
infected Tg BM cells in the upper well secreted soluble S
(factors including type I IFNs that aborted DC develop-
ment from wt BM cells (lack hSLAM MV receptor) in m
Mthe bottom well (data not shown). In contrast, BM cells
deficient in IFNAR in the bottom well normally dif- y
pferentiated into DCs when they were similarly cocul-
tured with Tg BM cells infected with MV in the upper p
twell (Figure 4A). This result indicates again that type I
IFN inhibits DC differentiation directly by binding to its t
tcognate receptor. Intriguingly, this inhibition was not
dependent on the expression of STAT1, STAT4, or
ISTAT6, because BM cells from either STAT1−/− (Figure
4A, 62% to 7%), STAT4−/− (42% to 19%), or STAT6−/− e
a(55% to 8%) mice (data not shown for STAT4−/− and
STAT6−/−) were unable to differentiate into DCs in the e
Opresence of MV-induced soluble factors. In contrast,
STAT2 was required for MV-induced inhibition of DC ex- n
ipansion. The inhibition of DC differentiation did not oc-
cur in the absence of STAT2 (72% to 68%), indicating m
aMV-induced type I IFNs signal through STAT2 to sup-
press DC development. STAT1(−) cells used in this
study (Figure 4A) were from mice known to express N L
vterminus truncated STAT1-related protein, which was
expressed at low levels and shown to be inactive in W
imost type II IFN and several type I IFN signaling path-
ways (Meraz et al., 1996). To exclude the role of this m
struncated STAT1 protein in the inhibition of DC develop-
ment, we performed studies with additional STAT1 gene w
fknockout mice (designated 2nd STAT1−/−) that com-letely lack STAT1 protein (Durbin et al., 1996). As be-
ore, no difference in suppression of DC generation was
bserved between BM cells from STAT1−/− mice ex-
ressing truncated STAT1 and BM cells from 2nd
TAT1−/− mice that are completely devoid of STAT1-like
rotein (Figure 4B). Thus, inhibition of DC development
as observed in wt and STAT1(−) cells from two dif-
erent sources, but not in STAT2(−) cells (Figure 4B),
learly demonstrating STAT1-independent, but STAT2-
ependent, inhibition of DC generation. Thus, these
tudies ruled out a role for truncated STAT1 expressed
n STAT1(−) cells used in Figure 4A. Further, rIFN-β
lone triggered STAT1-independent, but STAT2-depen-
ent, type I IFN signaling resulting in suppression of DC
evelopment (Figure S3), suggesting the existence of
ovel IFN signaling specific to DC precursors.
To examine whether MV-induced type I IFNs activate
TAT2 protein, tyrosine phosphorylation of STAT2
pYSTAT2) was analyzed. MV-treated BM cells from Tg
ice or STAT1(−), but not STAT2(−), cells incubated with
V-induced soluble factors in a transwell experiment
ielded pYSTAT2 at 5, 10, 20 (Figure 4C), and 72 hr
ostcultures. Levels of total STAT2 protein as well as
YSTAT2 were elevated in the cells that lost their ability
o differentiate into DCs (Figure 4C). No correlation be-
ween STAT1 activation and inhibition of DC differentia-
ion was detected (data not shown).
On/off of downstream signaling triggered by type I
FN/STAT2 was further investigated by detecting RNA
xpression of a type I IFN-stimulated gene, 2#–5# oligo-
denylate synthetase (OAS). IFN-stimulated response
lement (ISRE)-dependent transcriptional activation of
AS gene was induced in Tg and STAT1(−) cells, but
ot in IFNAR(−) and STAT2(−) cells (Figure 4D), which
s consistent with the results demonstrating a STAT2-
ediated pathway for suppression of DC differenti-
tion.
CMV Cl 13 Interferes with DC Expansion
ia STAT2 Signaling In Vivo
e then asked if these observations occur in an in vivo
nfection and occur with a different virus indicating a
ore general phenomenon. For this purpose, we
tudied an immunosuppressive variant of LCMV, Cl 13,
hose natural host is rodents and that preferentially in-
ects DCs via surface expression of its receptor α-dys-
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(A) Transwell experiment was performed with 0.4 µm cell culture inserts containing mock-infected (Tg) or MV-infected Tg BM cells (Tg + MV)
in upper well. Either IFNAR(−), STAT1(−), or STAT2(−) BM cells were cultured in the bottom well, and their differentiation into CD11c+MHC
class II+ DCs was assessed by flow cytometry.
(B) Similar transwell experiment was performed as described in (A), culturing BM cells from wt, STAT1−/−, 2nd STAT1−/− obtained from David
E Levy’s group, or STAT2−/− mice in the bottom well. Generation of CD11c+MHC class II+ DCs from two different STAT1(−) cells in the presence
of Tg or Tg + MV in upper well was shown in the top panel. Bar graphs ([B], bottom) indicate the production of CD11c+ DCs from wt, STAT1(−),
2nd STAT1(−), or STAT2(−) cells. Data shown are a representative of duplicate experiments performed at two different time points.
(C) Proteins in whole-cell extracts from Tg cells at 20 hpi or 20 hr after coculture ([A], STAT1−/− or STAT2−/−) were analyzed by Western blot
using antibodies to STAT2, phospho-STAT2 (Tyr689), and Actin.
(D) RNAs were isolated from either mock-infected or MV-treated cells from Tg or Tg × IFNAR−/− mice or cells from either STAT1−/− or STAT2−/−
mice in transwell experiment (A) at 20 hr after culture. RT-PCR analysis was carried out to detect RNA transcripts of OAS and β-actin.troglycan (Cao et al., 1998; Sevilla et al., 2000). It had
been suggested that LCMV suppresses host immune
responses by impairing hematopoiesis of BM cells
(Binder et al., 1997) and DC development (Sevilla et al.,
2004) that appeared to be linked to the type I IFN sig-
naling pathway. To further evaluate the contributions of
type I IFNs to Cl 13-mediated immune suppression,
mice lacking STAT1, STAT2, STAT4, or STAT6 were in-
fected with Cl 13 and treated with Flt3-L, and DC ampli-
fication assessed. Similar to wt mice, STAT1−/−, STAT4−/−,
or STAT6−/− mice were unable to induce DC proliferationand accumulation within the spleen and BM in re-
sponse to Flt3-L (Figure 5A, data not shown for BM
cells and STAT4−/− and STAT6−/−). In contrast, mice defi-
cient in STAT2 signaling were able to respond to Flt3-L
and induced DC expansion to levels observed in unin-
fected, Flt3-L-treated mice (Figure 5A). Similar to de-
fects observed after Flt3-L treatment, Cl 13 infection
also suppressed DC expansion within the spleen of wt,
STAT1−/−, STAT4−/−, or STAT6−/−, but not STAT2−/−, mice
without the treatment of Flt3-L during the acute stage
of disease (data not shown).
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(A) Splenic DCs were isolated from Cl 13-infected or uninfected wt, STAT1−/−, or STAT2−/− mice after injections with either Flt3-L or PBS for
10 days (see Figure 5A). Representative dot blots indicate the expansion of CD11c+CD8α− and CD11c+CD8α+ DCs within the spleen. Percent-
ages within boxes indicate the frequency of CD11c+ cells. Bar graphs ([A], bottom) indicate the fold increase in the total numbers of CD11c+
DCs detected in Flt3-L-treated mice compared to mice injected with PBS where the asterisk indicates a p value of <0.001. Each experiment
was performed in triplicate with three mice per group (n = 9). Data represent mean ± SD from three independent experiments.
(B) RNAs were isolated from purified splenic DCs (purity > 95%) of mice infected with either ARM or Cl 13 at 3, 5, 7, 20, and 50 dpi and used
in RT-PCR analysis to detect mRNAs of type I IFN (IFN-α). At days 3 and 5, densitometric analysis indicated that DCs from Cl 13-infected
mice produced 2-fold and 4-fold more type I IFN mRNAs than did a similar number of DCs from ARM-infected mice, respectively. Experiments
were performed in duplicate with mRNA pooled from 20 mice per group. Similar results were obtained with DCs from BM.
(C) Flt3-L- or PBS-injected wt or STAT2−/− mice were treated with either rIFN-β or PBS for 12 days (n = 6). Fold increase in the total numbers
of CD11c+ DCs was analyzed. The asterisk indicates a p of value <0.001. Data represent mean ± SD from two independent experiments.
(D) Total BM cells were obtained from PBS-injected or Cl 13-infected wt (*p < 0.001), STAT1−/− (*p < 0.01), or STAT2−/− mice at 15 dpi (n = 5).
Bar graphs indicate the frequency of DC progenitors observed within the BM, defined as lineage (B220, CD11b, Gr-1, Ter119, CD5, and CD3)
negative and Flt3 positive. Experiment repeated two additional times with similar results.LCMV infection, like those by many viruses, results t
pin systemic type I IFN production (Diebold et al., 2003).
We investigated the correlation between virus-induced e
1suppression of DC expansion and type I IFN production
by DCs. For this purpose, we determined the mRNA <
samounts of type I IFNs produced in purified DCs from
mice infected with the immunosuppressive LCMV Cl 13 2
dor nonimmunosuppressive Armstrong strain of LCMV
(ARM). During acute infection, LCMV Cl 13 infects c
b>75% of splenic DCs and >20% of both BM plasmacy-oid and myeloid DCs (data not shown) and causes a
rofound and generalized immunosuppression (Evans
t al., 1994; Sevilla et al., 2000, 2004; Tishon et al.,
993), whereas LCMV ARM infects <10% of splenic and
5% of BM DCs (data not shown) and immunosuppres-
ion does not occur (Ahmed et al., 1984; Sevilla et al.,
000). LCMV Cl 13 was derived from LCMV ARM and
iffers by only two amino acids, with a Leu in viral gly-
oprotein at aa 260 in Cl 13 as compared to Phe in ARM
eing responsible for DC infection and immunosup-
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253pression (Sevilla et al., 2000). Synthesis of type I IFNs
in DCs after ARM infection occurred only up to 5 dpi
and not thereafter (Figure 5B). In contrast, Cl 13 in-
duced 4-fold greater synthesis of type I IFN (IFN-α and
IFN-β) from DCs within the spleen and BM than LCMV
ARM at 5 dpi and continually made type I IFN through-
out the 50 day observation period (Figure 5B), a period
when a generalized humoral and cellular immunosup-
pression occurred (Sevilla et al., 2000, 2004). These
data indicate a direct correlation between virus that in-
fects DCs, produces high levels of type I IFN in such
cells, and causes immunosuppression from those
viruses that do not or only infect low levels of DCs,
generate minimal levels of type I IFN from such cells,
and fail to cause immunosuppression. The data further
implies a common strategy whereby viruses that can
infect DCs preferentially abort DC development through
the release of type I IFN at the site of precursor differen-
tiation, resulting in fewer DC available to prime T cells
and generate antiviral responses. Interestingly, blood
levels of type I IFNs were equivalent between LCMV
Cl 13 and LCMV ARM early in infection, owing to the
generalized replication of both viruses in multiple tis-
sues (data not shown).
Next, we determined whether a type I IFN molecule
was directly immunosuppressive when administered
parentally. To assay for this effect, Flt3-L-treated, unin-
fected wt, and STAT2−/− mice were injected intraperito-
neally (i.p.) with 10,000 U of rIFN-β. The result was a
dramatic reduction in DC expansion in wt, but not
STAT2−/−, mice (Figure 5C, p < 0.001) thereby recapitu-
lating the events observed with the LCMV Cl 13 or MV
infections (Figures 1–5).
As early DC progenitors are within the Flt3+ precursor
population (D’Amico and Wu, 2003), we next deter-
mined whether Cl 13 infection was able to affect the
frequency of the lineage (Lin) negative Flt3+ population.
Interestingly, Cl 13 infection of wt mice significantly re-
duced the frequency (p < 0.001, Figure 5D) and total
numbers (data not shown) of Flt3+ undifferentiated DC
progenitors in the absence of Flt3-L treatment. In
agreement with the observed impairment in DC expan-
sion, this reduction is also mediated by type I IFN (data
not shown) and occurs in a STAT2-dependent, but
STAT1-independent, pathway (p < 0.01, Figure 5D).
Discussion
We report here that MV suppresses DC development
from hematopoietic BM cells. The underlying mecha-
nism is mediated by antiproliferation and antidifferenti-
ation, but not apoptotic activity exhibited by type I IFNs
produced by MV replication. The molecular mechanism
is via a STAT2-dependent, but STAT1-independent,
novel signaling pathway. The finding of STAT2-specific
signaling for DC suppression is also observed in an
in vivo infection with the immunosuppressive LCMV Cl
13 virus. A study with LCMV infection in vivo further
demonstrates that one mechanism by which Cl 13 sup-
presses host immune responses is by reducing the fre-
quency of early DC progenitors (Figure 5D), which re-
sults in decreased DC population.
Immunosuppression induced by MV infection lastsfor several weeks to months and remains even after
MV is cleared from the host. MV impairs hematopoiesis
(Manchester et al., 2002), which may contribute to
lengthening the duration of immune suppression. We
were able to corroborate and extend these findings by
showing that MV aborts the ability of hematopoietic BM
stem cells to form DCs (Figure 1). By inhibiting DC de-
velopment, MV infection influences the host’s ability to
mount both innate and adaptive immune responses,
which likely makes infected humans susceptible to op-
portunistic infections (Slifka et al., 2003). Moreover, MV
also inhibits DC production of IL-12 (Figure 1D), a cy-
tokine pivotal in pushing Th1 type immune responses,
which may explain in part the biased cytokine response
of Th2 phenotype observed in measles patients (Karp
et al., 1996).
Both Flt3-L and GM-CSF are regulatory cytokines im-
portant for generating DCs (Inaba et al., 1992; Mc-
Kenna, 2001). Flt3-L-dependent DC development was
reported as mediated by STAT3 activation (Laouar et
al., 2003), whereas regulation of STAT1 activation was
implicated in GM-CSF-derived maturation of DCs
(Jackson et al., 2004). Virus-induced type I IFNs may
impair developmental program of DCs by shifting sig-
naling cascades among STAT proteins. It is unlikely that
MV V protein inhibited the role of STAT3 as reported
(Palosaari et al., 2003), leading to inhibition of STAT3-
dependent DC development in Flt3-L supplemented
culture, as we found that MV infection without the ex-
pression of V protein retained the inhibitory activity on
DC generation (Figure S2B). However, it is possible that
MV has evolved separate strategies to regulate STAT
signaling depending on cell type specificity, as two in-
dependent groups reported MV V protein inhibited a
distinct stage of STAT signaling in cell types (Palosaari
et al., 2003; Takeuchi et al., 2003) different than the DCs
studied here.
Until this report, the accumulative evidence indicated
a requirement of both STAT1 and STAT2 in type I IFN
response in numerous systems (Aaronson and Horvath,
2002; Darnell et al., 1994; Durbin et al., 1996; Meraz et
al., 1996; Park et al., 2000). Our report here of STAT2-
dependent inhibition of DC development is the first
phenotypic example, to our knowledge, resulting from
a STAT1-independent and STAT2-specific signaling
pathway. IFNs were previously shown to regulate prolif-
erative responses in cells of the mononuclear phago-
cyte lineage derived from STAT1-deficient mice, in-
dicating the existence of a STAT1-independent IFN
signaling pathway (Ramana et al. 2001; Gil et al. 2001).
Moreover, in vitro studies indicate that overexpression
of STAT2 and IRF9 in human cell lines can signal in the
absence of STAT1, although this complex did not re-
store intact activity of type I IFNs (Bluyssen and Levy,
1997). It remains unresolved whether the role of STAT1
in stabilizing ISGF3 complex on ISRE (Bluyssen and
Levy, 1997) is not necessary or substituted by another
factor in DC precursor cells. Perhaps, significant upreg-
ulation of STAT2 protein and sustained STAT2 activation
on DC precursor cells by virus-induced type I IFNs nul-
lify the necessity of STAT1.
Despite extensive studies analyzing the role of type I
IFN in DC differentiation, data suggest that type I IFNs
can have either a positive or a negative influence.
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dal., 2003; Ito et al., 2001; Luft et al., 1998; McRae et al.,
p2000 Mohty et al., 2003; Paquette et al., 1998; Santodo-
rnato et al., 2003). The contradictory effects may be, in
vpart, explained by the diverse sources of hetero-
wgeneous DCs including DC precursors, immature DCs,
eand mature DCs used for investigations. Moreover, diffi-
aculties in separating homogeneous DC populations, es-
2pecially with in vitro culture system of human DCs gen-
Serated from monocytes, may produce effects ranging
tfrom altering DC development to influencing matura-
wtion. By contrast, in this report, we separated develop-
sment of precursor DCs from maturation of DCs by using
both in vitro and in vivo systems. This allowed us to
odemonstrate that virus-induced type I IFNs specifically
pinhibit DC development of DC precursor. Further, our in
svitro culture system also documents positive stimula-
ttion on the maturation of committed DCs after DCs are
adeveloped from BM cells, (Figure 3B). Thus, our results
wclarify previous contradictory findings and indicate that
dthe state of maturity and homozygosity of the DC sub-
cpopulations is critical.
BInterestingly, although type I IFN production can be
sformed in areas where DC maturation occurs, neverthe-
sless, MV and LCMV Cl 13 infection results in inhibition
cof DC terminal maturation (Hahm et al., 2004; Servet-
Delprat et al., 2000; Sevilla et al., 2004). MV and LCMV
ECl 13 both appear to have devised multiple pathways
to inhibit DCs and attest to the necessity of antigen
Cpresentation for protective adaptive and innate immune
B
responses. Our results further extend the dynamic rep- a
ertoire viruses possess that allows them to effectively U
(inhibit the host immune responses. In this case, infect-
ting DCs and releasing type I IFNs that subvert the host
protective immune response thereby give the virus a
2
selective advantage in persistence. k
Evidence presented here that two disparate viruses,
MV and LCMV, induce the release of type I IFNs and S
2activate STAT2 resulting in suppression of DC develop-
ement, reveals that type I IFNs can act as a double-
medged sword. One edge protects most cells from viral
S
infection by activating both STAT1 and STAT2, thereby
limiting viral spread and providing an opportunity for
Mgeneration of an effective immune response. By the op-
Fposite edge, type I IFNs interfere with DC development
f
through STAT2 activation on DC precursor cells, offer- M
ing a selective advantage for virus to survive by limiting C
the numbers of DCs available for the induction of T cell
responses. By subverting the IFN response, viruses en-
T
hance their survival by disallowing/aborting the devel- B
opment of the antiviral adaptive immune responses. w
The fact that this mechanism occurs with two dissimilar 
cviruses that both cause a profound immunosuppres-
Ssion suggests that this may be a common mechanism
rused by other viruses that induce immunosuppression
a
and/or by several viruses that persist. Other viruses in- t
duce the production of type I IFNs but do not induce
immunosuppression, likely because they do not infect
PDCs preferentially and do not produce type I IFNs at
C
the site of DC development. We could duplicate the e
suppression by MV and LCMV using rIFN-β both in vitro l
Fand in vivo. This result further suggests that local con-entration as well as cell type specificity is critical in
etermining a positive or negative outcome in DC sup-
ression. DCs are critical components in host immune
esponses against pathogens, and viruses have de-
ised several strategies to abort and/or usurp DC net-
ork (Andrews et al., 2001; Colonna, 2004; Geijtenbeek
t al., 2000; Hahm et al., 2004; Li et al., 2002; Raftery et
l., 2001; Salio et al., 1999; Schneider-Schaulies et al.,
003; Servet-Delprat et al., 2003; Sevilla et al., 2004;
teinman et al., 2003). The IFN/STAT2-mediated inhibi-
ion of DC development reported here is an additional
ay for viruses to evade host adaptive immune re-
ponses and/or establish persistence.
Lastly, observation that rIFN-β suppresses DC devel-
pment suggests a mechanism of how this molecule
rotects against an autoimmune disease like multiple
clerosis (Teige et al., 2003) presumably by dampening
he generation of antigen-specific T cells. Our results
lso suggest ways to enhance the beneficial but some-
hat limited efficacy of type I IFN in treating several
iseases caused by tumors and infectious agents, in-
luding hepatitis C virus (Pawlotsky, 2003) and hepatitis
virus (Eto and Takahashi, 1999), and provide new in-
ight for development of novel drugs targeting STAT2
ignaling, suggesting they are likely to improve the effi-
iency of type I IFN therapies.
xperimental Procedures
ells, Viruses, and Mice
M cells were harvested and either directly analyzed for FACS
nalysis or cultured with RPMI complete medium containing 200
/ml rmGM-CSF (Peprotech) (Hahm et al., 2004) or 100 ng/ml Flt3-L
Amgen Inc.). In some instances, LPS (Sigma) at 1 g/ml was used
o increase maturation of DCs.
Wt MV, JW strain was passaged on B95-8 cells (Hahm et al.,
004). LCMV Cl 13 and Armstrong 53b were grown in baby hamster
idney cells and titered on Vero cells (Sevilla et al., 2004).
Mice were maintained in the closed breeding colony of The
cripps Research Institute. CD11c-hSLAM Tg mice (Hahm et al.,
004), IFNAR−/− mice (Muller et al., 1994), and STAT2−/− mice (Park
t al., 2000) are described elsewhere. Two different lines of STAT1−/−
ice were used (Meraz et al., 1996; Durbin et al., 1996; termed 2nd
TAT1−/−).
V Infection Analysis
or MV infection, nonadherent cells were incubated with either MV-
ree cell supernatant (mock infection), MV-V(−), or MV at 0.3–0.5
OI on ice for 2 hr. After washing, cells were recultured in GM-
SF- or Flt3-L-supplemented media.
ranswell Experiment
M cells harvested from Tg mice were mock infected or infected
ith MV as described above and added in cell culture insert (0.4
m pore for 6 well or 12 well; Becton Dickinson and Company). BM
ells obtained from wt, IFNAR−/−, STAT1−/−, 2nd STAT1−/−, STAT2−/−,
TAT4−/−, or STAT6−/− mice were added to the bottom well. The
atio of cell number used between cells in the upper well (insert)
nd cells in the bottom well was 1:1. After 5 days, cells cultured in
he bottom well were analyzed by FACS.
roliferation Assay
ells were labeled with carboxyfluorescein diacetate succidimyl
ster (CFSE; Molecular Probes) and then infected with MV. The
evel of CFSE fluorescence from nonadherent cells was traced by
ACS at days 0, 3, and 5. After 5 days of culture, loosely adherent
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255cells formed several large colonies (about 2–4 mm in diameter) on
6-well culture plates, which were identified as CD11c+ DCs when
they were isolated, stained with DC-specific antibodies (CD11c+
and MHC-II+) or antibodies specific to other immune cells, and ex-
amined by FACS. DC colonies formed during the culture were visu-
alized by staining with 0.1% crystal violet.
Apoptotic Analysis
BM cells were either mock infected or infected with MV and cul-
tured with complete media containing GM-CSF. At 2, 3, 4, and 5
dpi, nonadherent cells were incubated with Annexin V-FITC and
7-amino-actinomycin D (7-AAD) (Pharmingen). After staining, cells
were acquired and analyzed by FACS (Hahm et al., 2004).
RT-PCR Analysis
Total RNA was purified by using Tri-reagent (Molecular Research
Center). For LCMV studies of IFN levels after Cl 13 or ARM infec-
tion, RNAs were obtained from CD11c+ DCs isolated from the
spleens or BMs of infected mice at 3, 5, 7, 20, and 50 dpi (n = 20
mice per time point) via two passes on positive-selection columns
with anti-CD11c magnetic antibodies (miltenyi biotec) (purity of
CD11c+ cells >95%). Experimental conditions for RT-PCR reaction
including primer sequences are provided in the Supplemental Data.
For IFN-α subtyping, amplified RT-PCR product of IFN-α was di-
gested with KpnI and EcoRI and ligated with pSK(−) vector. 21
transformed colonies were randomly selected and sequenced to
identify the subtype of IFN-α produced by MV-infected cells.
Western Blot Analysis
Immunoblot analysis was performed with antibodies against
STAT2, phospho-STAT2 (Tyr689) (Upstate), and Actin (Santa Cruz
Biotechnology) as primary antibodies and a horseradish peroxi-
dase-linked anti-rabbit or mouse immunoglobin G as a secondary
antibody. Membrane bound antibodies were detected by enhanced
chemiluminescence (Cell Signaling Technology).
Flt3-L Treatment of Mice
Mice were injected i.p. daily for ten consecutive days with 10 g of
Flt3-L (Amgen, Inc.) resuspended in 200 l of sterile PBS. Control
mice were injected with 200 l PBS alone.
In Vivo LCMV Infection Analysis
4- to 6-week-old C57BL/6, C57BL/6 × 129, BALB/C, STAT1−/−,
STAT2−/−, STAT4−/−, and STAT6−/− mice were infected by intrave-
nous inoculation with 2 × 106 PFU of LCMV Cl 13. At 20 dpi, mice
were injected with either Flt3-L or sterile PBS as described above.
All mice were sacrificed at 30 dpi, and spleen and BM were re-
moved for analysis. For splenic DC analysis, whole spleens were
digested with collagenase D (1 mg/ml, type II, Sigma-Aldrich) for 20
min at 37°C. Single cell suspensions were obtained by mechanical
disruption and analyzed by FACS.
Treatment with rIFN-
For in vitro treatment, rIFN-β (Research Diagnostics, Inc.) in serial
dilutions was added to BM cells or BM-derived DCs in the GM-
CSF- or Flt3-L-supplemented media at days 0, 2, and 4 after cul-
ture. For in vivo experiments, mice were injected with 10,000 U of
rIFN-β resuspended in 200 l sterile PBS or PBS alone daily for 12
days. At day 2 post rIFN-β injections, mice were also treated with
either Flt3-L or sterile PBS for ten consecutive days. Data are de-
rived from three experiments with at least two mice per group
(n = 6).
Flow Cytometric Analysis
Antibodies used in this study were specific for murine CD4, CD8α,
B220, Ter119, Flt-3, CD11c, Gr-1, CD5, CD3, CD11b, I-A/I-E MHC
class II, IL-12, CD40, B7-1, and B7-2 antibodies (BD PharMingen
or e-Bioscience). For intracellular staining of IL-12, cells were
treated with 4 g/ml Brefeldin A (Sigma). Cells were stained with
fluorescent antibodies as described (Hahm et al., 2004), acquired
with a FACSCalibur flow cytometer (Becton Dickinson), and ana-lyzed with FlowJo (Treestar) software. All FACS data shown are
representative of at least three independent experiments.
Supplemental Data
Supplemental Data including three figures, Supplemental Results,
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